EUFOREA Symposium: What is the importance of the initiatives EUFOREA is taking? Miquel Diaz Pascual
Respiratory conditions are not a priority not only at a European level but also globally. Miquel Díaz from Sanofi shares the importance of having a big community of patient groups with medical societies joining forces to elevate the awareness of the conditions (lower and upper airways) and to work together in providing more educational materials to patients where they can find reliable information to self-advocate of their own diseases. Miquel Believes that EUFOREA is filling the huge gap in upper airways and is the only organisation focusing on upper respiratory airways.
🗣 Interview with Miquel Díaz Pascual, Public Affairs Head for Respiratory Diseases at Sanofi, at the @europeanparliament in Brussels on 17 April 2024. Learn from Miquel Díaz Pascual (#spain):
1. What are your key takeaways from this EUFOREA Symposium?
2. What is the importance of the initiatives EUFOREA is taking?
👉 Learn more about this initiative here: https://www.euforea.eu/events/raising...
--------------------------------------------------------------------------------------------------------------------------
📽 Subscribe to our YouTube Channel for our latest videos on Allergies and Airway Diseases
http://bit.ly/3eMvc3E
--------------------------------------------------------------------------------------------------------------------------
📧 Get in touch with the EUFOREA team for any questions
http://bit.ly/2OtlIQp
--------------------------------------------------------------------------------------------------------------------------
📌 EUFOREA is an international non-profit organisation aiming to implement optimal patient care for allergies and airway diseases (asthma, chronic rhinosinusitis, rhinitis) and comorbidities through education, research and advocacy. #euforea
📍Follow us on social media
Twitter: http://bit.ly/38wrrM7
LinkedIn: http://bit.ly/2OqtWsf
Instagram: http://bit.ly/3TGB5jM
Facebook: http://bit.ly/3cnNyFF
Spotify (podcast): https://bit.ly/3yBa2l3